Sponsor content
839 result(s) found, displaying 121 to 130
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR RIVAROXABAN rivaroxaban 10 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR RIVAROXABAN rivaroxaban 15 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIVOXA rivaroxaban 20 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIVOXA rivaroxaban 10 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR RIVAROXABAN rivaroxaban 20 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIVOXA rivaroxaban 15 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RIVOXA rivaroxaban 2.5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR RIVAROXABAN rivaroxaban 2.5 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CHEMISTS’ OWN CHILDREN’S HAYFEVER & ALLERGY RELIEF CHEWS loratadine 5 mg chewable tablet blister pack.